Avita Medical (ASX: AVH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Avita Medical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Avita Medical (ASX: AVH)
Latest News
Growth Shares
2 ASX growth stocks that could turn $10,000 into $30,000 by 2030
Cheap Shares
Have $500? 2 absurdly cheap ASX shares I think long-term investors should buy right now
Share Fallers
Why Avita Medical, Deep Yellow, Piedmont Lithium, and Syrah shares are falling today
Investing Strategies
How I'd invest $40k to create a lifelong passive income of $36,000 a year
Share Gainers
Why Avita Medical, Core Lithium, Silex, and South32 shares are storming higher today
Healthcare Shares
3 ASX healthcare shares that could make you a millionaire
Investing Strategies
Investing in these 3 ASX shares now could make you a millionaire retiree
Investing Strategies
The 3 best deals on the ASX today
Investing Strategies
Do you want to tell your boss where to go? Read this
Cheap Shares
I would grab these cheap ASX shares before prices rise again
Healthcare Shares
Why is the Avita Medical share price crashing 14% today?
Share Gainers
The Avita Medical share price just leapt 17%! What's going on?
Frequently Asked Questions
-
No, AVITA Medical does not pay dividends at this time.
-
AVITA Medical Inc listed on the ASX on 24 June 2020.
-
Yes, as well as being listed on the ASX, AVITA Medical Inc is listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.
AVH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Avita Medical
AVITA Medical Inc (ASX: AVH) is a healthcare company specialising in regenerative medicine. It is best known for its RECELL system, a burn treatment device that creates 'spray-on skin' from a patient's own skin cells within 30 minutes, avoiding or reducing the need for skin grafts.
The product was originally invented and patented by Western Australian doctor and clinical professor Fiona Wood in 1993.
RECELL is approved for use in Australia, Europe, Canada, China, the Middle East, and Africa. It is also approved for treating adult patients in the US. As well as burns, AVITA Medical has evidence of RECELL's effectiveness for additional skin applications, such as treating chronic and traumatic wounds, scar revision, and vitiligo.
AVITA Medical Inc is domiciled and also listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.